GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Health In Tech HIT · USD

Financials · US listing · 🇺🇸 United States

Compare

0.61

+8.75%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue, before interest expense

$33.3m

FY2022FY2025

Net income

$1.3m

FY2022FY2025

Total assets

$23.1m

FY2022FY2025

Shareholders' equity

$17.1m

FY2022FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022
Revenue, before interest expense$33.3m$19.5m$19.2m$5.8m
Research and development$1.6m$2.8m$2.0m$794,617
Operating income$1.5m$989,904$3.4m$205,582
Net income$1.3m$670,477$2.5m$79,742
Diluted earnings per share0.020.010.050.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022
Total assets$23.1m$15.8m$11.5m$28.6m
Cash and short-term investments$7.7m$7.8m$2.4m$1.5m
Total liabilities$6.0m$2.6m$5.4m$27.1m
Debt$139,812$206,692$1.9m$316,090
Shareholders' equity$17.1m$13.2m$6.1m$1.1m
Shares outstanding59m54m54m63m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue, before interest expense$8.1m$8.8m$7.5m$8.5m$9.3m$8.0m$4.9m$4.5m
Operating income−$3.4m−$2.2m−$170,813$493,523$725,070$480,658−$316,336$438,882
Net income−$2.5m−$1.6m−$302,557$452,176$630,631$498,592−$144,152$376,086
Diluted earnings per share-0.04-0.03-0.010.010.010.01-0.000.01
Total assets$31.1m$29.0m$23.1m$22.8m$22.2m$21.3m$15.8m$9.7m
Cash and short-term investments$6.5m$10.3m$7.7m$8.0m$8.1m$7.6m$7.8m$1.7m
Debt$81,225$78,680$76,195$73,769$71,418$69,122$66,881$64,692
Shareholders' equity$19.6m$21.6m$17.1m$17.2m$16.4m$14.2m$13.2m$6.9m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue79.5%——
Operating income95.2%——
Net income152.2%——

Valuation history

At each fiscal year end

FY2025FY2024
Price to earnings72.976.4
Price to sales2.82.7

Share price return

Finished calendar years

2025
Return51%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.